SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 6/22/20 THC Therapeutics, Inc. 10-Q 4/30/20 60:3.1M Discount Edgar/FA |
Document/Exhibit Description Pages Size 1: 10-Q Quarterly Report HTML 403K 2: EX-31.1 Certification -- §302 - SOA'02 HTML 22K 3: EX-31.2 Certification -- §302 - SOA'02 HTML 22K 4: EX-32.1 Certification -- §906 - SOA'02 HTML 17K 5: EX-32.2 Certification -- §906 - SOA'02 HTML 17K 28: R1 Cover HTML 50K 49: R2 Consolidated Balance Sheets HTML 89K 40: R3 Consolidated Balance Sheets (Parenthetical) HTML 42K 15: R4 Consolidated Statement of Operations (Unaudited) HTML 71K 29: R5 Consolidated Statements of Stockholders Deficit HTML 95K (Unaudited) 51: R6 Consolidated Statement of Cashflows (Unaudited) HTML 95K 42: R7 Description of Business and History HTML 23K 13: R8 Basis of Presentation and Going Concern HTML 22K 32: R9 Summary of Significant Policies HTML 35K 26: R10 Fixed Assets HTML 25K 22: R11 Intangible Assets HTML 25K 36: R12 Advances From Related Parties HTML 29K 57: R13 Related Party Transactions HTML 24K 25: R14 Secured Notes Payable HTML 31K 21: R15 Convertible Notes Payable HTML 44K 35: R16 Convertible Notes Payable Related Party HTML 21K 56: R17 Derivative Liability HTML 29K 27: R18 Stock Warrants HTML 25K 20: R19 Shareholders Deficit HTML 42K 44: R20 Subsequent Events HTML 23K 48: R21 Summary of Significant Policies (Policies) HTML 79K 33: R22 Fixed Assets (Tables) HTML 24K 14: R23 Intangible Assets (Tables) HTML 25K 43: R24 Advances From Related Parties (Tables) HTML 29K 47: R25 Secured Notes Payable (Tables) HTML 30K 30: R26 Convertible Notes Payable (Tables) HTML 44K 12: R27 Derivative Liability (Tables) HTML 28K 41: R28 Stock Warrants (Tables) HTML 26K 50: R29 Basis of Presentation and Going Concern (Details HTML 26K Narrative) 59: R30 Summary of Significant Policies (Details HTML 31K Narrative) 37: R31 Fixed Assets (Details) HTML 30K 18: R32 Fixed Assets (Details Narrative) HTML 20K 23: R33 Intangible Assets (Details) HTML 28K 60: R34 Intangible Assets (Details Narrative) HTML 20K 38: R35 Advances From Related Parties (Details) HTML 28K 19: R36 Advances From Related Parties (Details Narrative) HTML 21K 24: R37 Related Party Transactions (Details Narrative) HTML 50K 58: R38 Secured Notes Payable (Details) HTML 24K 39: R39 Convertible Notes Payable (Details) HTML 36K 52: R40 Convertible Notes Payable Related Party (Details HTML 44K Narrative) 45: R41 Derivative Liability (Details) HTML 27K 16: R42 Derivative Liability (Details 1) HTML 40K 34: R43 Stock Warrants (Details) HTML 46K 53: R44 Stock Warrants (Details Narrative) HTML 23K 46: R45 Shareholders' Deficit (Details Narrative) HTML 262K 17: R46 Subsequent Events (Details Narrative) HTML 61K 54: XML IDEA XML File -- Filing Summary XML 103K 55: EXCEL IDEA Workbook of Financial Reports XLSX 58K 6: EX-101.INS XBRL Instance -- thct-20200430 XML 1.03M 9: EX-101.CAL XBRL Calculations -- thct-20200430_cal XML 120K 11: EX-101.DEF XBRL Definitions -- thct-20200430_def XML 433K 8: EX-101.LAB XBRL Labels -- thct-20200430_lab XML 667K 10: EX-101.PRE XBRL Presentations -- thct-20200430_pre XML 575K 7: EX-101.SCH XBRL Schema -- thct-20200430 XSD 147K 31: ZIP XBRL Zipped Folder -- 0001477932-20-003485-xbrl Zip 95K
docavgw0.htm |
EXHIBIT 32.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of THC Therapeutics, Inc. (the "Company") on Form 10-Q for the fiscal period ended April 30, 2020 (the "Report"), I, Brandon Romanek, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that:
1) | The Report fully complies with the requirement of Section 13(a) or 15 (d) of the Securities Exchange Act of 1934; and |
2) | The information contained in the Report fairly presents, in all material respects, the Company's financial position and results of operations. |
Date: June 22, 2020 | By: | /s/ Brandon Romanek |
|
|
|
| |
|
| Chief Financial Officer |
|
This ‘10-Q’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 6/22/20 | |||
For Period end: | 4/30/20 | NT 10-Q | ||
List all Filings |